Hearing Loss, Mixed
16
5
7
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
6.3%
1 terminated out of 16 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Evaluating the Safety of BONEBRIDGE Implants in Children Under Five Years Old: This Study Looks at Children Under Five Who Got BONEBRIDGE BCI 602 Implants. It Collects Information on Any Problems With the Device or the Surgery to See if it is Safe Within the First Year After the Operation.
Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients
Preschool Hearing Screening
Pediatric Expansion Study of the Sentio System
Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients
A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy
Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)
Expanded Indications in the Pediatric BONEBRIDGE Population
Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Investigating Hearing With the Ponto 4, a Bone Anchored Hearing Aid
BONEBRIDGE Bone Conduction Implant in Adults
Clinical Investigation Study of Safety and Performance of the Sentio System.
The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study
Subjective and Audiological Benefit of BONEBRIDGE (BCI602) With Two Different Fitting Strategies
Investigation of an Updated Bone-anchored Sound Processor
Evaluation of the Baha SoundArc in Pediatric Patients